Wenbin Jiang, CEO of Cytek Biosciences CTKB, has filed 0 purchases and 11 sales on the open market. The latest trade was on 05/18.

WJ

WJ

Wenbin Jiang

President and CEO

Company

Cytek Biosciences CTKB

First filing

23/01/10

Trades

144 trades

Buys / sales

0 / 11

12-month net buying

No record

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Cytek BiosciencesCTKB	Open-market sale	23/11/07	23/11/08	20,000 sh	$4.34	$86,800	−0.4%
Cytek BiosciencesCTKB	Open-market sale10b5-1 plan	23/10/09	23/10/11	20,000 sh	$5.33	$106,600	−0.4%
Cytek BiosciencesCTKB	Open-market sale	23/09/07	23/09/08	20,000 sh	$6.83	$136,600	−0.3%
Cytek BiosciencesCTKB	Open-market sale	23/08/07	23/08/08	20,000 sh	$9.04	$180,800	−0.3%
Cytek BiosciencesCTKB	Open-market sale10b5-1 plan	23/07/07	23/07/07	20,000 sh	$8.48	$169,600	−0.3%
Cytek BiosciencesCTKB	Open-market sale10b5-1 plan	23/06/07	23/06/07	20,000 sh	$8.23	$164,600	−0.3%
Cytek BiosciencesCTKB	Open-market sale10b5-1 plan	23/05/08	23/05/10	20,000 sh	$11.55	$231,000	−0.3%
Cytek BiosciencesCTKB	Open-market sale10b5-1 plan	23/04/10	23/04/11	20,000 sh	$8.88	$177,600	−0.3%
Cytek BiosciencesCTKB	Open-market sale	23/03/07	23/03/07	20,000 sh	$10.13	$202,600	−0.3%
Cytek BiosciencesCTKB	Open-market sale	23/02/07	23/02/08	20,000 sh	$13.19	$263,800	−0.3%
Cytek BiosciencesCTKB	Open-market sale	23/01/09	23/01/10	20,000 sh	$10.66	$213,200	−0.3%